RITUXIMAB AND SARGRAMOSTIM IMMUNOTHERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA

被引：0
|
作者：
Scigliano, E. [1 ]
Grosskreutz, C. L. [1 ]
Osman, K. [1 ]
Malone, A. [1 ]
Nieto, J. [1 ]
Isola, L. M. [1 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.167
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
136
引用
收藏
页码：S208 / S209
页数：3
相关论文
共 50 条
  • [31] Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
    Kruger, Paul C.
    Cooney, Julian P.
    Turner, J. Harvey
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (09) : 552 - 560
  • [32] Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
    Prinz, E
    Mitterbauer, M
    Keil, F
    Kalhs, P
    Mitterbauer, G
    Höcker, P
    Jäger, U
    Chott, A
    Mannhalter, C
    Greinix, H
    BONE MARROW TRANSPLANTATION, 2001, 27 : S272 - S272
  • [33] Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma
    Stiff, Patrick J.
    Unger, Joseph M.
    Cook, James R.
    Constine, Louis S.
    Couban, Stephen
    Stewart, Douglas A.
    Shea, Thomas C.
    Porcu, Pierluigi
    Winter, Jane N.
    Kahl, Brad S.
    Miller, Thomas P.
    Tubbs, Raymond R.
    Marcellus, Deborah
    Friedberg, Jonathan W.
    Barton, Kevin P.
    Mills, Glenn M.
    LeBlanc, Michael
    Rimsza, Lisa M.
    Forman, Stephen J.
    Fisher, Richard I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1681 - 1690
  • [34] Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL)
    BenYosef, R
    Braverman, I
    Saah, D
    Nagler, R
    Shohat, S
    Or, R
    Nagler, A
    BONE MARROW TRANSPLANTATION, 1996, 18 (05) : 1017 - 1019
  • [35] Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma
    Khurana, Arushi
    Hathcock, Matthew
    Habermann, Thomas M.
    Al Saleh, Abdullah S.
    Gandhi, Sangeetha
    Truong, Tuan
    Bennani, N. Nora
    Paludo, Jonas
    Villasboas, Jose C.
    Ansell, Stephen M.
    Inwards, David J.
    Porrata, Luis F.
    Johnston, Patrick B.
    Micallef, Ivana
    Lin, Yi
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) : E386 - E389
  • [36] Rituximab and Interleukin 2 for CD20 positive Non-Hodgkin's Lymphoma following autologous transplant.
    Holmberg, LA
    Maloney, DG
    Bensinger, WI
    BLOOD, 2002, 100 (11) : 646A - 647A
  • [37] Is autologous stem cell transplantation feasible in solid organ transplant recipients with non-Hodgkin's lymphoma?
    Jantunen, E.
    Pyorala, M.
    Kuittinen, T.
    Mantymaa, P.
    Koljonen, E.
    Kuittinen, O.
    Kuitunen, H.
    Nousiainen, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S421 - S422
  • [38] Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma
    Hoerr, AL
    Gao, F
    Hidalgo, J
    Tiwari, D
    Blum, KA
    Mathews, V
    Adkins, DR
    Blum, W
    Devine, S
    Vij, R
    Goodnough, LT
    Dipersio, JF
    Khoury, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4561 - 4566
  • [39] Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-hodgkin's lymphoma
    Akhtar, S
    Maghfoor, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6261 - 6261
  • [40] Lenalidomide and Rituximab Following Autologous Stem Cell Transplantation for B-Cell Non-Hodgkin Lymphoma Is Associated with Unacceptable Myelotoxicity
    Dean, Robert
    Pohlman, Brad
    Rybicki, Lisa
    Maggiotto, Amanda L.
    Bates, Jennifer
    Smith, Stephen D.
    Bolwell, Brian J.
    Sweetenham, John
    BLOOD, 2011, 118 (21) : 705 - 705
12345